Toward the precision use of Chinese PARP inhibitors in ovarian cancer: clinical progress, resistance mechanisms, and future perspectives. - Yu, Jing; Li, Maochen; Zhu, Yuhan; Wang, Shengnan; Jiang, Yuzhao; Cui, Wei; Wu, Lingying (Cancer Biology & Medicine, 2026)